 MORRISVILLE, N.C., Jan. 04, 2021 GLOBE NEWSWIRE -- Syneos Health Nasdaq:SYNH, the only fully integrated biopharmaceutical solutions organization combining a CRO Contract Research Organization and a CCO Contract Commercial Organization, today announced that Chief Executive Officer Alistair Macdonald is scheduled to present at the 39th Annual J.P. Morgan Healthcare Conference on January 13, 2021, at 8:20 a.m. EST. 